Michael Pawlita

Author PubWeight™ 186.18‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007 16.39
2 Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003 6.28
3 A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007 4.29
4 Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem 2005 4.18
5 Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol 2006 3.13
6 Suppression of non-specific binding in serological Luminex assays. J Immunol Methods 2005 2.96
7 Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol 2013 2.87
8 Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 2006 2.40
9 Helicobacter pylori protein-specific antibodies and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2013 2.01
10 HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. J Virol Methods 2002 1.97
11 Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers. J Clin Microbiol 2008 1.90
12 Biomarkers of HPV in head and neck squamous cell carcinoma. Cancer Res 2012 1.76
13 High-risk HPV types and head and neck cancer. Int J Cancer 2014 1.56
14 Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients. Gynecol Oncol 2002 1.56
15 Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. Int J Epidemiol 2011 1.55
16 Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay. J Clin Microbiol 2009 1.55
17 Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma. J Clin Oncol 2007 1.53
18 Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccination. Clin Cancer Res 2004 1.51
19 Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement. Cancer Res 2012 1.49
20 High-throughput detection and multiplex identification of cell contaminations. Nucleic Acids Res 2009 1.49
21 Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study. Am J Epidemiol 2013 1.48
22 High-throughput SNP-based authentication of human cell lines. Int J Cancer 2012 1.46
23 Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea. Cancer Epidemiol Biomarkers Prev 2007 1.45
24 Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog 2008 1.44
25 Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer 2013 1.42
26 Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer 2014 1.40
27 Human papillomavirus seropositivity and risks of head and neck cancer. Int J Cancer 2007 1.39
28 Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types. J Gen Virol 2008 1.35
29 Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology. Cancer Res 2009 1.33
30 Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma. Cancer Res 2010 1.30
31 Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study. Cancer Epidemiol Biomarkers Prev 2008 1.29
32 Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study. J Natl Cancer Inst 2013 1.29
33 Helicobacter pylori multiplex serology. Helicobacter 2009 1.29
34 Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease. J Oncol 2012 1.27
35 Race, African ancestry, and Helicobacter pylori infection in a low-income United States population. Cancer Epidemiol Biomarkers Prev 2011 1.26
36 Human papillomavirus type 16 and TP53 mutation in oral cancer: matched analysis of the IARC multicenter study. Cancer Res 2004 1.25
37 Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins. Cancer Res 2003 1.24
38 Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer. J Pathol 2014 1.23
39 A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2007 1.22
40 Versatile biosynthetic engineering of sialic acid in living cells using synthetic sialic acid analogues. J Biol Chem 2001 1.22
41 Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study. BMJ 2010 1.18
42 Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians. J Gen Virol 2010 1.16
43 Global hypomethylation identifies Loci targeted for hypermethylation in head and neck cancer. Clin Cancer Res 2011 1.15
44 T25 repeat in the 3' untranslated region of the CASP2 gene: a sensitive and specific marker for microsatellite instability in colorectal cancer. Cancer Res 2005 1.13
45 Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men. Cancer Epidemiol Biomarkers Prev 2012 1.13
46 Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions. Cancer Epidemiol Biomarkers Prev 2008 1.12
47 Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer. Int J Cancer 2010 1.12
48 Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice. J Virol 2003 1.12
49 Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach. Int J Cancer 2009 1.11
50 Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patients. J Cancer Res Clin Oncol 2003 1.10
51 Association between chronic atrophic gastritis and serum antibodies to 15 Helicobacter pylori proteins measured by multiplex serology. Cancer Res 2009 1.10
52 Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer. Int J Cancer 2012 1.10
53 Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later. Am J Obstet Gynecol 2003 1.09
54 InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markers. J Natl Cancer Inst 2012 1.09
55 Absence of SV40 antibodies or DNA fragments in prediagnostic mesothelioma serum samples. Int J Cancer 2007 1.07
56 Opium: an emerging risk factor for gastric adenocarcinoma. Int J Cancer 2013 1.06
57 Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers. Int J Cancer 2008 1.05
58 Diagnosing cervical cancer and high-grade precursors by HPV16 transcription patterns. Cancer Res 2009 1.05
59 Prospective study of human papillomavirus seropositivity and risk of nonmelanoma skin cancer. Am J Epidemiol 2012 1.04
60 Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3). Int J Cancer 2007 1.04
61 Case-control study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev 2012 1.04
62 HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas. Int J Cancer 2005 1.03
63 Case-control study of Merkel cell polyomavirus infection and cutaneous squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2011 1.02
64 High beta-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis. J Invest Dermatol 2008 1.02
65 Identification of oropharyngeal squamous cell carcinomas with active HPV16 involvement by immunohistochemical analysis of the retinoblastoma protein pathway. Int J Cancer 2013 1.02
66 Human papillomavirus serologic follow-up response and relationship to survival in head and neck cancer: a case-comparison study. Infect Agent Cancer 2011 1.01
67 Dynamics of human papillomavirus serology in women followed up for 36 months after pregnancy. J Gen Virol 2009 1.01
68 HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas. J Clin Invest 2013 1.01
69 Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities. J Clin Microbiol 2013 1.01
70 Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol 2014 0.99
71 Dried blood spot samples for seroepidemiology of infections with human papillomaviruses, Helicobacter pylori, Hepatitis C Virus, and JC Virus. Cancer Epidemiol Biomarkers Prev 2011 0.98
72 Presence of DNA of human papillomavirus 16 but no other types in tumor-free tonsillar tissue. J Clin Microbiol 2005 0.97
73 Association of seropositivity to Helicobacter species and biliary tract cancer in the ATBC study. Hepatology 2014 0.97
74 Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia. J Gen Virol 2009 0.97
75 Impact of capsid conformation and Rep-capsid interactions on adeno-associated virus type 2 genome packaging. J Virol 2006 0.96
76 Seroepidemiology of Human Polyomaviruses in a US Population. Am J Epidemiol 2015 0.96
77 Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: a case-control study. Int J Cancer 2008 0.95
78 A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology. Int J Cancer 2013 0.95
79 Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibility. Int J Cancer 2011 0.95
80 Prevalence of human papillomavirus types in cervical and oral cancers in central India. Vaccine 2008 0.95
81 Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort. Int J Cancer 2014 0.94
82 Serological detection systems for identification of cows shedding bovine foamy virus via milk. Virology 2007 0.94
83 Evaluation of different glutathione S-transferase-tagged protein captures for screening E6/E6AP interaction inhibitors using AlphaScreen. J Biomol Screen 2007 0.94
84 High-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomaviruses. PLoS One 2013 0.93
85 Human papillomavirus load in eyebrow hair follicles and risk of cutaneous squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2013 0.93
86 Human papillomavirus genotypes present in the oral mucosa of newborns and their concordance with maternal cervical human papillomavirus genotypes. J Pediatr 2011 0.93
87 Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer. Int J Cancer 2014 0.92
88 Measures of cutaneous human papillomavirus infection in normal tissues as biomarkers of HPV in corresponding nonmelanoma skin cancers. Int J Cancer 2008 0.92
89 Association of tooth loss and oral hygiene with risk of gastric adenocarcinoma. Cancer Prev Res (Phila) 2013 0.92
90 Restricted T-cell receptor repertoire in melanoma metastases regressing after cytokine therapy. Cancer Res 2003 0.92
91 Case-control study of genus-beta human papillomaviruses in plucked eyebrow hairs and cutaneous squamous cell carcinoma. Int J Cancer 2013 0.91
92 Prevalence and viral load of 51 genital human papillomavirus types and three subtypes. Int J Cancer 2012 0.90
93 Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with MYC rearrangement. J Pathol 2004 0.90
94 Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: evidence from the EPIC cohort. Int J Cancer 2014 0.89
95 An assay to quantify species-specific anti-JC virus antibody levels in MS patients. Mult Scler 2013 0.89
96 Cutaneous alpha, beta and gamma human papillomaviruses in relation to squamous cell carcinoma of the skin: a population-based study. Int J Cancer 2013 0.89
97 Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study. Int J Cancer 2013 0.89
98 The HPV transcriptome in HPV16 positive cell lines. Mol Cell Probes 2011 0.88
99 Redetection of cervical human papillomavirus type 16 (HPV16) in women with a history of HPV16. J Infect Dis 2013 0.88
100 Structures of B-lymphotropic polyomavirus VP1 in complex with oligosaccharide ligands. PLoS Pathog 2013 0.88
101 Case-control study of cutaneous human papillomavirus infection in Basal cell carcinoma of the skin. J Invest Dermatol 2013 0.87
102 Prevalence and stability of antibodies to 37 human papillomavirus types--a population-based longitudinal study. Virology 2010 0.87
103 Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus. BMC Infect Dis 2014 0.87
104 Circulating cytokines and gastric cancer risk. Cancer Causes Control 2013 0.87
105 Longitudinal study of seroprevalence and serostability of the human polyomaviruses JCV and BKV in organ transplant recipients. J Med Virol 2012 0.86
106 Epigenetically mediated loss of UDP-GlcNAc 2-epimerase/ManNAc kinase expression in hyposialylated cell lines. Biochem Biophys Res Commun 2003 0.86
107 Seroprevalence and determinants of eight high-risk human papillomavirus types in homosexual men, heterosexual men, and women: a population-based study in Amsterdam. Sex Transm Dis 2010 0.86
108 Human papillomavirus type 16 E2- and L1-specific serological and T-cell responses in women with vulval intraepithelial neoplasia. J Gen Virol 2003 0.86
109 Risk factors for cutaneous human papillomavirus seroreactivity among patients undergoing skin cancer screening in Florida. J Infect Dis 2010 0.86
110 Viral load of high-risk human papillomaviruses as reliable clinical predictor for the presence of cervical lesions. Cancer Epidemiol Biomarkers Prev 2013 0.85
111 C-terminal deletions of Merkel cell polyomavirus large T-antigen, a highly specific surrogate marker for virally induced malignancy. Int J Cancer 2012 0.85
112 Human polyomaviruses and other human viruses in neuroendocrine tumors. Cancer Epidemiol Biomarkers Prev 2011 0.85
113 Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7. J Cancer Res Clin Oncol 2003 0.85
114 Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patients. Int J Cancer 2014 0.84
115 Seropositivity to Helicobacter pylori and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2013 0.84
116 Occupational asbestos exposure is associated with pharyngeal squamous cell carcinoma in men from the greater Boston area. Occup Environ Med 2013 0.84
117 Enhancement of human papilloma virus type 16 E7 specific T cell responses by local invasive procedures in patients with (pre)malignant cervical neoplasia. Int J Cancer 2006 0.84
118 Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation. Head Neck 2013 0.84
119 Sunlight exposure and cutaneous human papillomavirus seroreactivity in basal cell and squamous cell carcinomas of the skin. J Infect Dis 2012 0.84
120 Reply to P.E. Castle. J Clin Oncol 2013 0.83
121 The Association between cutaneous squamous cell carcinoma and betapapillomavirus seropositivity: a cohort study. Cancer Epidemiol Biomarkers Prev 2011 0.83
122 Route of sexual exposure is independently associated with seropositivity to HPV-16 and HPV-18 among clients of an STI clinic in the Netherlands. J Infect Dis 2013 0.83
123 New JC virus infection patterns by in situ polymerase chain reaction in brains of acquired immunodeficiency syndrome patients with progressive multifocal leukoencephalopathy. J Neurovirol 2004 0.83
124 Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays--an update. Vaccine 2006 0.83
125 A case-control study of cutaneous squamous cell carcinoma among Caucasian organ transplant recipients: the role of antibodies against human papillomavirus and other risk factors. Int J Cancer 2009 0.83
126 Genome-wide association study of HPV seropositivity. Hum Mol Genet 2011 0.82
127 The HPV16 transcriptome in cervical lesions of different grades. Mol Cell Probes 2011 0.81
128 No association between antibodies to sexually transmitted infections and colorectal hyperplastic polyps in men: Minnesota Cancer Prevention Research Unit Polyp Study. Cancer Epidemiol Biomarkers Prev 2012 0.81
129 Obesity and head and neck cancer risk and survival by human papillomavirus serology. Cancer Causes Control 2014 0.81
130 Serological prevalence and persistence of high-risk human papillomavirus infection among women in Santiago, Chile. BMC Infect Dis 2014 0.81
131 Prevalence, incidence, and risk factors for human papillomavirus 16 seropositivity in Australian homosexual men. Sex Transm Dis 2012 0.81
132 Seroreactivity of 38 human papillomavirus types in epidermodysplasia verruciformis patients, relatives, and controls. J Invest Dermatol 2009 0.81
133 Prospective study of genital human papillomaviruses and nonmelanoma skin cancer. Int J Cancer 2013 0.80
134 Helicobacter pylori prevalence and circulating micronutrient levels in a low-income United States population. Cancer Prev Res (Phila) 2011 0.80
135 Epstein-Barr virus and risk of non-Hodgkin lymphoma in the cancer prevention study-II and a meta-analysis of serologic studies. Int J Cancer 2014 0.79
136 Longitudinal study of seroprevalence and serostability of 34 human papillomavirus types in European organ transplant recipients. Virology 2012 0.78
137 Lack of association between the presence and persistence of betapapillomavirus DNA in eyebrow hairs and betapapillomavirus L1 antibodies in serum. J Gen Virol 2010 0.78
138 Evidence of the causal role of human papillomavirus type 58 in an oropharyngeal carcinoma. Virol J 2013 0.77
139 Evaluation of a novel multiplex human papillomavirus (HPV) genotyping assay for HPV types in skin warts. J Clin Microbiol 2011 0.77
140 The seroprevalence of human papillomavirus by immune status and by ethnicity in London. Infect Agent Cancer 2009 0.77
141 Human papillomavirus types 6 and 11 seropositivity: risk factors and association with ano-genital warts among homosexual men. J Infect 2013 0.77
142 A case of recurrent respiratory papillomatosis with malignant transformation, HPV11 DNAemia, high L1 antibody titre and a fatal papillary endocardial lesion. Virol J 2014 0.77
143 The Natural History of Human Polyomaviruses and Herpesviruses in Early Life-The Rhea Birth Cohort in Greece. Am J Epidemiol 2016 0.76
144 Increased frequency of JC-polyomavirus detection in rheumatoid arthritis patients treated with multiple biologics. Med Microbiol Immunol 2015 0.76
145 Antibodies against Gag are diagnostic markers for feline foamy virus infections while Env and Bet reactivity is undetectable in a substantial fraction of infected cats. Virology 2005 0.76
146 Multiplex H. pylori Serology and Risk of Gastric Cardia and Noncardia Adenocarcinomas. Cancer Res 2015 0.76
147 Genotyping of AAV plasmid stocks: quality control in adeno-associated virus vector production. J Mol Microbiol Biotechnol 2010 0.76
148 Detection and typing of cutaneous human papillomavirus types--a comparison of three different methods. J Virol Methods 2012 0.76
149 Diet, Helicobacter pylori strain-specific infection, and gastric cancer risk among Chinese men. Nutr Cancer 2014 0.76
150 The sero-epidemiology of human papillomavirus among Caucasian transplant recipients in the UK. Infect Agent Cancer 2009 0.75
151 Correction: The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort. PLoS One 2016 0.75
152 Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay. Hum Vaccin Immunother 2014 0.75
153 HIV is an important risk factor for human papillomavirus types 16 and 18 seropositivity among sexually active men who have sex with men. Sex Transm Dis 2015 0.75